Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Biomarkers
Filter     Order     Display # 
Date Item Title Hits
27 Jul 2010 Exact Sciences Obtains Exclusive License to OncoMethylome Sciences' DNA Methylation Biomarkers 23
04 Jun 2010 TauRx Enters Collaborative R&D Agreement with Bayer Schering Pharma 375
03 Jun 2010 Philips and RXi Pharmaceuticals Sign Agreement to Jointly Research Innovative Image-Guided Therapy Concepts Based on RNAi 82
11 May 2010 bioMérieux and GlaxoSmithKline Enter into Alliance to Develop Molecular Theranostic Test for Cancer Treatment Selection 898
30 Apr 2010 New Data from Phase III Lung Cancer Trial Show VeriStrat(R) Identifies Patients Likely to Respond to Erlotinib 199
09 Apr 2010 GE Healthcare Presents Positive Phase 2 Data with Flutemetamol - Phase 3 Program Now Underway 279
08 Apr 2010 Debiopharm Group and Biocartis embark on a partnership aiming at enhancing personalized medicine 114
18 Feb 2010 Preliminary Data from Roche ATHENA Cervical Cancer Trial Support Value of Human Papillomavirus Genotyping 477
17 Feb 2010 Roche Collaborates with Merck on Developmental Test for Cancer-Related Gene Mutation 219
05 Feb 2010 QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients 213
18 Jan 2010 AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments 297
12 Jan 2010 Kinaxo Extends its Collaboration with Roche 172
30 Nov 2009 Bayer Starts Phase III Trial with Florbetaben 175
29 Nov 2009 WILEX AG receives preliminary results of the phase III trial with the diagnostic REDECTANE 407
30 Oct 2009 Bayer HealthCare Presents Florbetaben Phase II Study Results at World Congress of Neurology 416
22 Oct 2009 GE and Lilly Achieve Significant Advancement in Cancer Research 332
11 Aug 2009 Dako enters collaboration with Genentech on diagnostic tests for patients with stomach cancer 821
14 Jul 2009 Abbott and GSK to Collaborate on Molecular Diagnostic Test to Select Candidate Patients for Future Cancer Immunotherapy 464
29 May 2009 Boehringer Ingelheim and DxS sign an agreement for a companion diagnostic to identify EGFR mutations in patients with lung cancer 575
26 May 2009 KineMed Enters Into Collaboration With Bristol-Myers Squibb 378
21 May 2009 Almac Announces Collaboration With Pfizer and The PETACC3 Translational Research Working Party, Focused on Molecular Subtyping and Biomarker Identification in Colorectal Cancer 303
25 Nov 2008 Dako enters new collaboration with Genentech on a companion diagnostic for a targeted cancer therapy 7800
13 Apr 2008 Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 1888
19 Mar 2008 Vermillion Announces Positive Results From Clinical Trial of Ovarian Tumor Triage Test; Study Meets Primary Endpoints 1182
16 Nov 2007 The New England Journal of Medicine Publishes First Clinical Results for MedImmune's Chitinase-like Protein YKL-40 in Patients With Asthma 1276
15 Oct 2007 Celera and Collaborators Identify a Five-gene Genetic Risk Score(TM) that Predicts Risk of Coronary Heart Disease 1335
02 Aug 2007 GTC Biotherapeutics and LFB Biotechnologies developing CD20 Antibody 2296
16 Jul 2007 PreMD Signs Marketing and Distribution Agreement with AstraZeneca 1481
28 May 2007 Miraculins Announces Positive Final Results in Pivotal Prostate Cancer Biomarker Study 1758
23 May 2007 Organon and Philips team up to study drug effects at the molecular level 2137
 
<< Start < Prev 1 2 3 4 Next > End >>
Results 1 - 30 of 101

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Tau and Amyloid Beta Targeted Therapy of Alzheimer’s Disease

Order Now

Recommended Report

R&D Drug Pipeline Database
Order Now

Subscribe La Merie Biologics